Overview
Financials
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Bank accounts
Registered as a VAT taxpayer on 2025-12-15. Active
10 2530 0008 2060 1088 7268 0001
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Taora currently holds no active trademarks with the Polish Patent Office. 1 application is pending. The first mark was filed in 2026.
| Mark | Protected until | |
|---|---|---|
| TAORA | – |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mateusz Garnier (35) | 50 | $675.31 | 50% |
Rafał Gref (37) | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Noble Healthsp. z o.o. | $4,558,481.50 | noblehealth.com | ||
| Natura Organicasp. z o.o. | $128,773.68 | naturaorganica.pl | ||
| Propharmsp. z o.o. | $25,859.81 | propharm.pl | ||
| Vianatsp. z o.o. | $20,652.52 | vianat.eu | ||
| Vasco Techsp. z o.o. | $18,452.60 | vascotech.pl | ||
| Symbio PolskaS.A. | $9,938.92 | symbio.pl | ||
| BEE & Sonssp. z o.o. | $8,782.50 | beeandsons.com | ||
| Noblepharma Bissp. z o.o. | $0.19 | noblepharma.pl | ||
| Nticosmetics.Comsp. z o.o. | – | nticosmetics.com | ||
| Wendysp. z o.o. | – | wendy.com.pl |
FAQ
Last updated: 2026-07-09